Similar Papers

Paper Title
Journal
Date
Author
Blood transcriptomic biomarkers for tuberculosis screening: time to redefine our target populations?
Rishi Kumar Gupta ... Mahdad Noursadeghi
The Lancet Global Health | VOL. 9
Rishi Kumar Gupta, et. al.Rishi Kumar Gupta ... Mahdad Noursadeghi
13 Apr 2021
Pathology, Molecular Biology, and Pathogenesis of Avian Influenza A (H5N1) Infection in Humans
Christine Korteweg ... Jiang Gu
The American Journal of Pathology | VOL. 172
Christine Korteweg, et. al.Christine Korteweg ... Jiang Gu
01 May 2008
Research and development for neglected diseases: more is still needed, and faster.
Jürg Utzinger ... Jennifer Keiser
The Lancet Global Health | VOL. 1
Jürg Utzinger, et. al.Jürg Utzinger ... Jennifer Keiser
26 Nov 2013
Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe
Corinne Levy ... Robert Cohen
The Journal of Pediatrics | VOL. 213
Corinne Levy, et. al.Corinne Levy ... Robert Cohen
24 Sep 2019
View more papers

More From: The Lancet Infectious Diseases

Paper Title
Journal
Date
Author
Efficacy of 8-aminoquinolines for Plasmodium vivax malaria radical cure: only one part of the problem
Marcus Lacerda ... Márcio Cortez
The Lancet Infectious Diseases | VOL. -
Marcus Lacerda, et. al.Marcus Lacerda ... Márcio Cortez
01 Jan 2025
Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study
Katia Alves ... Pedro Ylisastigui
The Lancet Infectious Diseases | VOL. -
Katia Alves, et. al.Katia Alves ... Pedro Ylisastigui
01 Jan 2025
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics
Constanze Ciavarella ... Michael White
The Lancet Infectious Diseases | VOL. -
Constanze Ciavarella, et. al.Constanze Ciavarella ... Michael White
01 Jan 2025
Interim analysis of SARS-CoV-2 vaccine NVX-CoV2601 as a heterologous booster dose
Pragya D Yadav ... Deepak Y Patil
The Lancet Infectious Diseases | VOL. -
Pragya D Yadav, et. al.Pragya D Yadav ... Deepak Y Patil
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.